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bstract
ntroduction: Interest increases in the role of the natural environment providing health benefits. This study compared forest and city walking on
rterial stiffness and pulmonary function.
ethods: A single-centre, parallel, randomised, and controlled, open-label trial was conducted. Seventy women >60 years were recruited into
he study. The forest-walking group walked around a forested area for 1 h. The city-walking group walked around an urban area for 1 h. Blood
ressure, arterial stiffness (CAVI), and pulmonary function (FEV1, FEV6) were assessed before and 30 min after the walking activity.
esults: Of the 70 women randomly assigned to the forest walking (n = 50) or city walking (n = 20) groups. Eight participants were excluded
rom analysis due to early dropout leaving43 participants in the forest-walking group and 19 in the city-walking group. One hour of forest walking
ignificantly improved CAVI (p < 0.01), FEV1 (p < 0.01) and FEV6 (p < 0.01). No significant change was observed in the city-walking group. There
ere significant differences in changes of CAVI (p < 0.01), FEV1 (p = 0.02), and FEV6 (p = 0.04), between the city-walking and the forest-walking
roups. No significant side effects were reported.
onclusion: Our results showed that forest walking improved arterial stiffness and pulmonary function in 61 elderly Korean women. Further large
cale and long-term studies are needed to better understand the clinical significance of these findings. Clinical trial registered with www.cris.org
KCT0000631).
2013 Elsevier GmbH. All rights reserved.
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There is growing interest in the role of environment in
uman health. Environmental stressors such as air pollution
nd crowding in urban areas substantially increases stress [1].
n contrast, the natural environment has positive health effects
2]. A forest environment is one of the most accessible ways
o experience the natural environment. Forests have been con-
idered human resting places for a long time because of their
eautiful scenery, fresh air, and quiet atmosphere. In Korea,
orest bathing and “taking in” the forest atmosphere are the
ost popular activities associated with forests [3]. Many stud-
es have evaluated the effects of forest bathing on human
∗ Corresponding author. Tel.: +82 2 2228 2330; fax: +82 2 362 2473.
E-mail addresses: jeeyon14@yuhs.ac (J.-Y. Lee), faith@yuhs.ac
D.-C. Lee).
1 Tel.: +82 2 2228 2330; fax: +82 2 362 2473.
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ealth [4–9]. Walking in forests has been shown to reduce lev-
ls of stress hormones [4,5], sympathetic nerve activity [6,7],
nd anxiety [7]. In addition, green spaces, such as forests
nd urban parks, are considered to help people recover from
ental stress through soft stimulation without additional men-
al effort [1]. A previous study demonstrated EEG changes
n participants who moved closer to trees in the urban city
green space) [8]. The EEGs indicated reduced frustration
nd arousal with an increased meditative state. Recent stud-
es show that forest environments also affect cardio-metabolic
arameters. Walking in a forest significantly reduces blood
ressure [6,4] and fasting glucose levels [9]. Although the
recise mechanism(s) underlying these findings is unknown,
he harmonies of each forest element are considered impor-
ant. Among them, many have studied the beneficial roles of
ree phytoncides (tea tree oils). Phytoncides regulate autonomic
unction [10] and have anti-oxidant properties [11] that affect the
uman body both through the olfactory pathway and the blood
tream.
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Atherosclerosis is one of the most common diseases among
he elderly and significantly increases the risk of cardiovascular
isease and mortality [12,13]. Chronic activation of sympathetic
one [14], and increased oxidative stress [15,16], with aging,
romote atherosclerosis. Pulmonary function decreases with age
17,18] and can lead to adverse outcomes and mortality in older
opulations [19,20]. Although various factors affect pulmonary
unction, chronic accumulation of oxidative stress [21,22] and
utonomic dysfunction [23] are known to lead to a decline in
ulmonary function.
Because forest environments have been associated with
hanges in the autonomic nerve system and have anti-oxidant
nd anti-inflammatory properties, forest environments may also
ffect arterial stiffness and pulmonary function; however, cur-
ent studies have not evaluate these relationships, and contain
ittle information about the effects of forests on the elderly.
e, therefore, investigated the acute effects of forest walking
n arterial stiffness and pulmonary function in Korean elderly
omen.
ethods
articipants
We completed an unbalanced, randomised [2:1], open-
abel, parallel-group study involving people aged 60–80 years
onducted in Korea. The study population was recruited by
dvertisement at the Senior Welfare Center in Mokpo City.
lthough we intended to recruit males and females, more than
5% of participants were female by the time approximately
0% of participants had been recruited. Therefore, we added the
nclusion criteria that participants must be females aged 60–80
ears. All subjects participated in the study voluntarily, and writ-
en informed consent was obtained from each participant. The
tudy complied with the Declaration of Helsinki and the insti-
utional review board of Yonsei University College of Medicine
pproved this study.
Participants with a history of chronic liver disease, chronic
enal disease, coronary artery occlusive disease, cerebro-
ascular disease, dementia, and/or cancer were excluded.
omen who had difficulties with walking because of dis-
bility or pain were also excluded as were participants with
lood pressures higher than 160/100 mmHg. This resulted in 70
ubjects who were then included into the study. Screening inter-
iews were conducted at the public health center by a trained
urse.
Participants were randomly assigned to groups by computer-
enerated random selection of numbers. This simple randomisa-
ion procedure resulted in a 1:2 allocation into the forest versus
ity-walking group. Participants were asked to visit the public
ospital of Mokpo city on either November 17th or 24th 2012
t 7:00 am and were not informed about their group assignment.
andom allocation and assignment were performed by nurses
orking in the public hospital in Mokpo city. They assisted
he study process as volunteers who were not involved in data
nalysis.
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tudy design
The forest-walking and the city-walking experiments were
onducted separately (1 week apart) on different days. On Sat-
rday, November 17, 2012, the forest-walking group visited
he pyunback tree (Chamaecyparis obtuse) forest in Janghung,
okpo City. The altitude of the forest was 150 m, and the surface
as flat without inclines or declines. On Saturday, November 24,
012 the city-walking group visited an urban area in Mokpo City.
o control for variance, city walking took place at an altitude
nd on a surface similar to those in the forest setting. The alti-
ude of the urban area was 50 m, and the surface was flat, paved,
nd lacked inclines or declines and lacked trees. On November
7, during the forest walking, the weather was clear, tempera-
ures ranged from 13.3 to 20.1 ◦C, and humidity was 52.3%. The
ate for city-walking was selected based on a similar weather
orecast. Walking in the city took place on November 24. The
eather was also clear, the temperatures ranged from 14.4 to
9.4 ◦C, and humidity was 55.4%.
Participants walked at their usual pace for 1 h in the morning
round the forest/urban area. Participants were educated about
he walking protocol before the study began. Walking at a usual
ace was defined as walking with normal breathing and without
weating, becoming over heated, or experiencing palpitations,
nd as if they were moving between the rooms in their house
t a relaxed pace. Five assistants were placed in the walking
rea (within 10 km from the starting places) in case of an acci-
ent or a participant became lost. Assistants also monitored
alking speed and distance. Participants were not permitted
o go further than 10 km from the starting places. During the
eriod of walking, we restricted entry of non-participants into
he walking areas. Anthropometric, arterial stiffness, and pul-
onary function measurements were obtained before and 30 min
fter walking activities. All of the measurements took place in
comfortable and quiet room, and each measurement was per-
ormed by one well-trained family medicine doctor. Because
ach test required about 5 min for completion, we divided par-
icipants into three groups to reduce the time and to standardize
he time point for the forest- and city-walking groups. To control
or the effects of caffeine and alcohol, the participants were not
llowed to consume beverages that contained caffeine or alcohol
uring the experiments.
easurements
All subjects completed a questionnaire about lifestyle,
ncluding smoking, alcohol consumption, and exercise. Smok-
ng was defined as current cigarette smoking, and alcohol
onsumption was defined as either drinking alcohol more fre-
uently than once per week or drinking 70 g or more of alcohol
er week. Regular exercise was defined as physical exercise
erformed three times per week for either 30 min or more.
he hypertension group (n = 21) was defined as subjects who
sed anti-hypertensive medicine; the diabetes group (n = 9) was
efined as subjects who used either insulin or oral hypoglycemic
edicine; and the dyslipidemia group (n = 5) was defined as
ubjects who used a lipid-lowering agent. Blood pressure was
al of
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easured in the subjects’ right arms in sitting positions after
10-min resting period using a mercury sphygmomanome-
er (Baumanometer®, W.A. Baum Co., Copiague, NY, USA).
lood pressure was measured twice for each subject, with 5-min
ntervals. We recorded average values for the analysis. The inter-
ssay coefficient of variation (CV) for blood pressure was 7.2%.
t was calculated from two repeated measurements of blood pres-
ure obtained at more than 1-week intervals in 20 elderly women.
ody mass index (BMI) was calculated as weight (kg) divided
y height squared (m2). Each subject was standing when the
aist circumference was measured midway between the lowest
ibs and the iliac crest [24].
easurement of pulmonary function
Pulmonary function was measured with a portable, Vitalo-
raph, Copd-6 meter. One well-trained family medical doctor
erformed all spirometric tests in a standardized manner to
educe variability. In a sitting position, participants took a deep
reath and inserted the mouthpiece into their mouths while hold-
ng their breath. The subjects blew vigorously and continuously
or 6 s. After 6 s, the device alarm beeped to inform the par-
icipants that they could stop blowing. During the exercise, we
ecorded forced expiratory volume in 1 s (FEV1) and forced
xpiratory volume in 6 s (FEV6). The maneuver was performed
hree times for each subject and we selected the best values
n each case. The inter-assay CV values of pulmonary function
FEV1, FEV6) provided by the manufacturer were less than 3%.
easurement of CAVI
Cardio-ankle vascular index (CAVI) is a measure of arte-
ial stiffness of the artery from the heart to the ankles. As
rteriosclerosis progresses, the CAVI value becomes higher.
owered extensibility of the aorta causes onset of heart dis-
ase and is a factor determining prognosis. CAVI was measured
ith a VaSera VS-1000 instrument (Fukuda Denshi Co. Ltd.,
okyo, Japan), using previously described methods [25]. Sub-
ects were examined in their supine position after 10 min of bed
est. Electrocardiogram electrodes were placed on both wrists
P
U
93 assessed for eligib
43 analysed for the results 
50 assigned to forest-walking group 2
70 randomly assign
7 lost to follow-up: 6 did not 
visit on study day and 1 due 
to non-compliance 
Fig. 1. Flowchart of study designIntegrative Medicine 6 (2014) 5–11 7
nd a phonocardiogram was placed on the right sternum bor-
er of the second intercostal space. Cuffs were applied around
oth upper arms and ankles to detect brachial and ankle pulse
aves. Pulse wave velocity was measured by dividing pulse
ave length by the time needed for the pulse wave to propagate
rom the aorta, through the femoral artery, to the tibal artery of
he ankle. CAVI was calculated as:
AVI = a
[
2ρ
P
× ln
(
Ps
Pd
)
PWV2
]
+ b,
here Ps, systolic pressure, Pd, diastolic pressure,
P = Ps −Pd, p = blood density, and a and b were con-
tant. We recorded mean values of right and left CAVI. The
nter-coefficient of variance (CV) value of CAVI was 1.9%. The
nter-assay CV value of CAVI calculated from two repeated
easurements obtained at more than 1-week intervals in 20
lderly women was 3.9%.
tatistical analysis
We evaluated our study sample size with a two-sample
nequality t-test, using PASS v2008 (NCSS statistical software,
aysville, UT, USA). Our intended study sample provided a
ower of 80% for a one-sided α = 5%, assuming an average
AVI change of 0.5 [standard deviation (SD) = 0.6] between the
orest- and city-walking groups. The calculated sample size was
4, with 1:2 ratio between the city- and forest-walking groups.
he expected dropout rate was 20%.
Data are presented as means ± SDs. A Kolmogrov–Smirnov
oodness of fit test was performed to determine normality. To test
or significant differences from the baseline, we used a paired t-
est, for normally distributed data (systolic BP and diastolic BP),
nd a Wilcoxon paired rank test, for non-normal data (CAVI,
EV1 and FEV6). The differences of mean changes between the
wo groups were compared with a Student’s t-test, for normally
istributed data (systolic BP and diastolic BP), and a Mann-
hitney U test for non-normal data (CAVI, FEV1 and FEV6).
We performed all statistical analyses using the Statistical
ackage for the Social Sciences, v18.0, of SPSS (Chicago, IL,
SA). Statistical significance was set at p < 0.05.
ility 
0 assigned to city-walking group 
19 analysed for the results 
ed 
1 lost to follow-up due to 
high blood pressure on the 
initial measurement 
23 did not meet criteria and 
were excluded 
and subject participation.
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Table 1
Basic baseline characteristics.
Variables City-walking
group
Forest-walking
group
p-Value
Subjects, n 19 43
Age (years) 71.11 ± 5.80 70.19 ± 4.66 NS
BMI (kg/m2) 23.18 ± 2.70 24.32 ± 4.75 NS
Waist circumferences (cm) 83.44 ± 7.99 85.12 ± 7.57 NS
Blood pressure (mmHg)
Systolic 127.78 ± 15.14 122.30 ± 14.01 NS
Diastolic 81.83 ± 11.67 76.51 ± 11.16 NS
CAVIa 8.59 ± 0.98 8.32 ± 1.22 NS
Pulmonary function
FEV1a (L) 1.71 ± 0.39 1.54 ± 0.49 NS
FEV6a (L) 2.16 ± 0.51 2.03 ± 0.59 NS
Alcohol (n, %) 2 (10.5) 10 (23.3) NS
Regular exercise (n, %) 6 (31.6) 19 (44.2) NS
Hypertension (n, %) 8 (38.1) 13 (30.2) NS
Diabetes (n, %) 3 (15.8) 6 (14.0) NS
Dyslipidemia (n, %) 1 (5.3) 4 (9.3) NS
Data are expressed as mean ± SD or numbers (percentages). A
Kolmogrov–Smirnov goodness of fit test was performed to determine
normality.
a Values were non-normally distributed.
NS: not significant. Smoking was defined as current cigarette smoking. Alcohol
consumption was defined as either drinking alcohol more frequently than once
per week or drinking 70 g or more of alcohol per week. Regular exercise was
defined as physical exercise performed three times per week for 30 min or more.
The hypertensive group was defined as subjects who used anti-hypertensive
medicine. The diabetes group was defined as subjects who used insulin or oral
hypoglycemic medicine. The dyslipidemia group was defined as subjects who
used a lipid-lowering agent. BMI, body mass index; CAVI, coronary-ankle vas-
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Table 3
Mean changes in the clinical variables, during the study period for city-walking
and forest-walking groups.
Variables City-walking group Forest-walking group p
Blood pressure (mmHg)
Systolic −0.78 ± 11.52 −8.16 ± 12.57 0.03
Diastolic −0.78 ± 5.96 −7.35 ± 8.20 <0.01
CAVI −0.11 ± 0.51 −0.42 ± 0.72 <0.01
Pulmonary function
FEV1 (L) 0.01 ± 0.18 0.19 ± 0.26 0.02
FEV6 (L) 0.04 ± 0.20 0.22 ± 0.36 0.04
Data are expressed as mean ± SD. p-Values were calculated with a Student’s
t-test, for normally distributed data (systolic BP and diastolic BP), and a Mann-
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fular index; FEV1, forced expiratory volume for 1 s; FEV6, Forced expiratory
olume for 6 s.
esults
Of 50 people in the forest-walking group, six withdrew
ecause they could not reach? The study place on time, and one
iscontinued during the study because of non-compliance. Of 20
ubjects in the city-walking group, one was excluded because
f initial high blood pressure (systolic blood pressure >200 mm
g; participant moved to the public health center in Mokpoor assistance). We obtained final data for 43 participants in
he forest-walking group and 19 participants in the city-walking
roup (Fig. 1). w
able 2
linical variables at baseline, and after intervention, for city-walking and forest-walk
ariables City-walking group (n = 19) p
Baseline After city walking Mean differences
lood pressure (mmHg)
Systolic 127.78 ± 15.14 129.78 ± 14.53 2.00 ± 17.51 NS
Diastolic 81.83 ± 11.67 83.11 ± 8.94 1.28 ± 8.55 NS
CAVI 8.59 ± 0.98 8.70 ± 0.86 0.11 ± 0.51 NS
ulmonary function
FEV1 (L) 1.71 ± 0.39 1.72 ± 0.41 0.01 ± 0.04 NS
FEV6 (L) 2.16 ± 0.51 2.19 ± 0.55 0.04 ± 0.20 NS
ata are expressed as mean ± SD. p-Values were calculated with paired t-tests, for n
ank tests, for non-normal data (CAVI, FEV1 and FEV6). NS: not significant. CAVI,
orced expiratory volume for 6 s.hitney U test, for non-normal data (CAVI, FEV1 and FEV6).
Baseline characteristics of study participants are described
n Table 1. There were no significant differences between city-
nd forest-walking groups in age, BMI, waist circumference,
aseline blood pressure, baseline CAVI, and baseline pulmonary
unction. The frequency of alcohol intake, regular exercise,
ypertension, diabetes, and dyslipidemia were also similar in
oth groups.
Table 2 shows the clinical variables, at baseline and after
ntervention. In the city-walking group, no significant changes
n blood pressure, CAVI, and pulmonary function occurred after
he walking activity. Walking in the forest, however, significantly
ecreased systolic blood pressure, diastolic blood pressure, and
AVI, and it significantly increased FEV1 and FEV6 (p < 0.01).
Table 3 and Fig. 2 show the changes in clinical variables
etween the city- and forest-walking groups during the study
eriod. Significant differences in changes in systolic blood
ressure (p = 0.03), diastolic blood pressure (p < 0.01), CAVI
p < 0.01), FEV1 (p = 0.02), and FEV6 (p = 0.04) between the
ity- and forest-walking groups occurred. No significant side
ffects or harmful events were reported during the intervention
n either group.
iscussionIn this randomized, controlled study, we found that forest
alking significantly improved arterial stiffness as measured by
ing groups.
Forest-walking group (n = 43) p
Baseline After forest walking Mean differences
122.30 ± 14.01 112.05 ± 16.77 −10.26 ± 13.11 <0.01
76.51 ± 11.16 66.58 ± 13.70 −9.93 ± 11.15 <0.01
8.32 ± 1.22 7.90 ± 1.09 −0.42 ± 0.72 <0.01
1.54 ± 0.49 1.73 ± 0.42 0.19 ± 0.26 <0.01
2.03 ± 0.59 2.26 ± 0.51 0.22 ± 0.36 <0.01
ormally distributed data (systolic BP and diastolic BP), and Wilcoxon paired
coronary-ankle vascular index; FEV1, forced expiratory volume for 1 s; FEV6,
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aig. 2. Mean changes in arterial stiffness (CAVI) and pulmonary function (FEV1
epresent the significance of between-group differences in variable changes from
AVI and pulmonary function. These changes were not signifi-
ant in the city-walking group.
Forest environments have many positive effects on human
ealth, reducing stress levels and enhancing relaxation. Walk-
ng in forests is known to increase human immune function,
educe stress hormone levels, and regulate autonomic function
6,7,4,26]. Although many studies identify the health benefits
f forest environments, none have tested for changes in arterial
tiffness and pulmonary function. To the best of our knowl-
dge, this is the first study that has evaluated the effect of forest
nvironments on the elderly.
In our study, both systolic and diastolic blood pressure
ecreased significantly after forest walking, but did not change
fter city walking. This is consistent with previous studies: Park
t al. [26] reported a blood pressure lowering effect after 20 min
f forest walking in young male students; and Li et al. [4] showed
imilar results in healthy, middle-aged, males. In contrast to
hese studies, we enrolled subjects >60-years-old, for which
he prevalence of hypertension was much higher. We believe
tudying the effects of forest walking on blood pressure in the
lderly, who have a higher prevalence of hypertension and other
ardiovascular risk factors, is important.
The precise mechanisms that underlie the effects of forest
alking on arterial stiffness and pulmonary function remain
l
i
l6) for forest walking versus city walking at baseline and after walking p-values
eline to post-walking. Error bar = 95% confidence interval (CI).
nclear. We hypothesise the following. Firstly, forest envi-
onments have anti-oxidant and anti-inflammatory properties,
uch as those of phytoncide substances [10–12] produced by
he trees [11]. An in vivo study showed a phytoncide solu-
ion to have a protective effect against reactive oxygen species,
n human dermal fibroblasts [27]. The Pyunbak forest where
e conducted the forest-walking study has a large number
f C. obtuse trees that occupies more than 65 ha. C. obtuse
as various phytoncides, including -pinene, -pinene, tricy-
lene, camphene, and limonene [28]. Given that oxidative stress
ontributes to the development of atherosclerosis by disrup-
ing redox balance in the arterial wall, altering the vascular
ell adhesion molecule, and increasing vascular smooth muscle
ell growth [16]; an antioxidant can have an anti-atherogenic
ffect [15]. In a previous study, a one-day experience in a
orest significantly increased serum adiponectin levels [4].
diponectin is an adipocytokine that has anti-inflammatory and
nti-atherogenic properties [29]; therefore, the anti-oxidant and
nti-inflammatory properties of forest environments may influ-
nce arterial stiffness. Oxidative stress and inflammation are
lso related to a decline in lung function; oxidative stress stimu-
ates mucus production in epithelial cells and lung parenchymal
nflammation, thereby limiting the airway by narrowing its
umen of airway [30,31]. Anti-oxidant and anti-inflammatory
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roperties of forest environments may therefore have a protec-
ive effect on both vascular and pulmonary function.
Secondly, changes may occur in the autonomic nervous sys-
em. Forest walking significantly reduces urine adrenaline and
oradrenaline levels, which reflect sympathetic nerve activity
4]. Similarly, forest walking decreases the average low fre-
uency/high frequency ratio of heart rate variability, which is
ssociated with sympathetic nerve activity and increases the
verage power of the high frequency components associated
ith parasympathetic nerve activity [7,26]. The autonomic ner-
ous system has an important role in the regulation of the human
rgan system, including cardiovascular and pulmonary systems
32]; the sympathetic nervous system increases the tone of vas-
ular smooth muscle; and the parasympathetic nervous system
as the opposite role [33]. Impaired vaso-dilation is one of many
actors that worsens arterial stiffness [34]. The autonomic ner-
ous system also affects the bronchial smooth muscle cells. The
arasympathetic nervous system relaxes bronchial smooth mus-
le, which has a positive effect on pulmonary function [35].
orest environments may have positive effects on arterial stiff-
ess and pulmonary function by increasing parasympathetic
ervous system activity and by decreasing sympathetic nervous
ystem activity.
Finally, air pollution in the city may also explain our results.
ir pollution has various negative effects on human health,
ncluding effects on pulmonary and cardiovascular functions.
nhaled diesel exhaust and ozone gases increase cellular inflam-
ation and oxidative stress in the respiratory system and amplify
llergic reactions [36], which can compromise pulmonary func-
ion [37] and cause adverse effects on asthma [38]. Air pollution
lso has adverse effects on cardiovascular function through
arious mechanisms, including activation of the sympathetic
ervous system, increased systemic inflammation, endothelial
ysfunction, and direct harmful effects on the cardiovascular
ystem [39]. Acute exposure to high concentrations of air pollut-
nts is related with high blood pressure and atherosclerosis [40].
urthermore, trees have aerodynamic effects on air pollution by
equestering carbon monoxide and reducing the concentration
f air pollution [41,42]. Therefore, it is possible to hypothe-
ise that forest walking may have benefits on cardiopulmonary
unctions by reducing the harmful effects of air pollution.
This study has several limitations. Firstly, we did not perform
iochemical laboratory tests for either metabolic parameters or
tress-related hormones. Secondly, we only evaluated the imme-
iate effects of forest walking, suggesting the need for long-term
tudies to evaluate whether there are long term effects or benefits.
hirdly, we only enrolled elderly females; therefore, we cannot
eneralize our results to the entire population. Fourthly, forest
nd city walking took place on different days due to limited
esources. Furthermore, the measurements and walking activi-
ies for both groups were not performed at the same time point
ecause of differences in the study population and measurement
imes. Because we investigated the acute effects of forest walk-
ng, differences in the time points may affect the results of the
tudy. Fifthly, we did not monitor blood pressure, heart rate, and
alking speed during the interventions. Instead, we provided
bout 30 min of education before the study to teach participantsIntegrative Medicine 6 (2014) 5–11
bout the correct walking pace. In addition, five assistants mon-
tored the walking pace of participants during the interventions.
owever, variations in these factors among participants might
ffect the results. Finally, non-equal randomisation of the study
roups (70:20) may bias the results of the study.
In conclusion, walking in a forest environment, in contrast
o walking in a city, reduces arterial stiffness and increases
ulmonary function in Korean elderly women. Our collective
ndings suggest that forest environments may promote better
ealth and prevent cardiopulmonary diseases in older popula-
ions. Further large-sized and long-term studies are needed to
etter understand the clinical significance of our findings.
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